These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19248293)

  • 41. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
    Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
    J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do we still need lead-in dosing of nevirapine in HIV-infected patients who are receiving rifampicin-containing antituberculous therapy?
    Chang SY; Lin SW; Hung CC
    Clin Infect Dis; 2009 Nov; 49(9):1452-3; author reply 1453-4. PubMed ID: 19824849
    [No Abstract]   [Full Text] [Related]  

  • 43. Potential impact of early antiretroviral therapy on transmission.
    Pao D; Pillay D; Fisher M
    Curr Opin HIV AIDS; 2009 May; 4(3):215-21. PubMed ID: 19532053
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Data are lacking for quantifying HIV transmission risk in the presence of effective antiretroviral therapy.
    Wilson DP
    AIDS; 2009 Jul; 23(11):1431-3. PubMed ID: 19487904
    [No Abstract]   [Full Text] [Related]  

  • 45. News from the 12th annual CROI.
    Emery C
    Surviv News (Atlanta Ga); 2005; 16(3):6. PubMed ID: 16106550
    [No Abstract]   [Full Text] [Related]  

  • 46. Modeling CD4+ cell count increase over a six-year period in HIV-1-infected patients on highly active antiretroviral therapy in Senegal.
    De Beaudrap P; Etard JF; Diouf A; Ndiaye I; Guèye NF; Guèye PM; Sow PS; Mboup S; Ndoye I; Ecochard R; Eric D;
    Am J Trop Med Hyg; 2009 Jun; 80(6):1047-53. PubMed ID: 19478274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Scientific round table--highlights of the 16th CROI 2009. Focus on current therapy studies].
    Sankawa Y
    MMW Fortschr Med; 2009 Apr; 151(18):34-5. PubMed ID: 19769071
    [No Abstract]   [Full Text] [Related]  

  • 48. Kaposi's sarcoma, lymphoedema and gangrene in AIDS--a therapeutic challenge.
    Ebrahim S; Singh B; Moodley J; Ramdial PK
    S Afr J Surg; 2009 May; 47(2):62-3. PubMed ID: 19626783
    [No Abstract]   [Full Text] [Related]  

  • 49. Improvements in antiretroviral therapy outcomes over calendar time.
    Boyd MA
    Curr Opin HIV AIDS; 2009 May; 4(3):194-9. PubMed ID: 19532050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation.
    Grulich AE
    Curr Opin HIV AIDS; 2009 May; 4(3):183-7. PubMed ID: 19532048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complications & side effects. German researchers study breath test for uncovering mitochondrial damage.
    TreatmentUpdate; 2004; 16(7):9-10. PubMed ID: 17225283
    [No Abstract]   [Full Text] [Related]  

  • 52. Top stories of 2008. Newer drugs strikingly effective when given together.
    Sax PE
    AIDS Clin Care; 2009 Jan; 21(1):3. PubMed ID: 19222152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stavudine in antiretroviral therapy: is this the end?
    Brinkman K
    AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724
    [No Abstract]   [Full Text] [Related]  

  • 54. [Advance on targets and drugs for anti-HIV].
    Wang X; Ma H; Wen R
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(11):1454-9. PubMed ID: 19771882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The future of HIV vasculopathy when our patients are on antiretroviral therapy.
    Barry R
    S Afr J Surg; 2009 May; 47(2):58, 60. PubMed ID: 19626782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].
    Boer K; Nellen JF; Kreyenbroek ME; Godfried MH
    Ned Tijdschr Geneeskd; 2009; 153():B410. PubMed ID: 19785876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complications of HIV disease and antiretroviral therapy.
    Currier JS; Havlir DV
    Top HIV Med; 2009; 17(2):57-67. PubMed ID: 19401608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
    Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD
    Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 13th Conference on Retrovirus and Opportunistic Infections. Update on experimental HIV drugs. The newest, latest pipeline drugs from CROI.
    Sharp M
    Posit Aware; 2006; 17(3):17-9. PubMed ID: 16791956
    [No Abstract]   [Full Text] [Related]  

  • 60. Despair and hope in rural South Africa: the story of the antiretroviral drugs that are changing lives.
    Greenall J
    AIDS; 2008 Oct; 22(16):F1-3. PubMed ID: 18832868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.